help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellet, D.
Right arrow Articles by Assicot, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellet, D.
Right arrow Articles by Assicot, M.

Endocrinology, Vol 115, 330-336, Copyright © 1984 by Endocrine Society


ARTICLES

A monoclonal antibody against a synthetic peptide is specific for the free native human chorionic gonadotropin beta-subunit

D Bellet, JM Bidart, M Jolivet, A Tartar, JM Caillaud, M Ozturk, MC Strugo, F Audibert, H Gras-Masse and M Assicot

A totally synthetic molecule (109-145 peptide) analogous to the beta- subunit carboxyl terminus was used as an antigen in the development of antibodies by the hybridoma technique. A monoclonal antibody (702 D7) specifically recognized the free native beta-human CG (beta hCG). 702 D7 was of the immunoglobulin G1 subclass and was directed against an antigenic site localized in a 10-amino acid sequence (109-118) or less. The recognition of an epitope located in the 109-118 region could explain the specific recognition of beta hCG observed with 702 D7, in contrast to monoclonal antibodies directed against a 118-145 region with a recognition of both beta hCG and whole hCG, as observed with a second monoclonal antibody (1032) to synthetic peptide. Immunohistochemical results and preliminary data obtained from the immunoradiometric assay show that 702 D7 provides a clinical tool for the detection of free beta-subunit secretion even at low concentrations, and could allow the study of this subunit or its metabolites produced by normal and tumoral cells.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Hatakeyama, C. Ohyama, S. Minagawa, T. Inoue, H. Kakinuma, A. Kyan, Y. Arai, T. Suga, J. Nakayama, T. Kato, et al.
Functional Correlation of Trophinin Expression with the Malignancy of Testicular Germ Cell Tumor
Cancer Res., June 15, 2004; 64(12): 4257 - 4262.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society